D. Ligocka et al., THE DISPOSITION AND METABOLISM OF 1,3,5-[U-C-14]TRIOXANE IN MALE WISTAR ALBINO RATS, Archives of toxicology, 72(5), 1998, pp. 303-308
The present study was designed to investigate 1,3,5-[U-C-14]trioxane (
TOX) distribution, excretion and metabolism. The experiments were perf
ormed on male Wistar albino rats after a single administration of TOX
at doses of 40 mg/kg and 400 mg/kg. The exhaled air proved to be the m
ain route of C-14 elimination, mainly as (CO2)-C-14. During the first
12 h following the administration of 40 mg/kg of TOX the exhalation of
(CO2)-C-14 was monophasic, with a half-life of 3.5 h. After the admin
istration of 400 mg/kg, TOX was eliminated mainly as (CO2)-C-14 with t
he exhaled air (77%) and unchanged TOX (8%). About 3% of C-14 was excr
eted in the urine as unchanged 1,3,5-trioxane. With regards to TOX eli
mination from blood plasma for the lower dose, a biphasic process was
observed, with half-lives of 4.5 and 72 h. The amount of C-14 bound by
the erythrocytes was minute compared with the amount in blood plasma.
When the higher dose of TOX was administered the efficiency of C bind
ing to the erythrocytes was found to be 10 times higher than the respe
ctive value for blood plasma. Among the examined tissues the highest c
oncentration of TOX-derived radioactivity was detected in the liver wh
ile the lowest was in fat tissue and brain. A subsequent decay of radi
oactivity occurred in the tissues. The results of the present study in
dicate that TOX belongs to the group of compounds, which are rapidly e
liminated from the organism; hence TOX should not be expected to accum
ulate within the tissues. The data obtained confirm the assumed patter
n of metabolic transformation, according to which 1,3,5-trioxane under
goes enzymatic transformation to formaldehyde, with carbon dioxide and
water being the final products.